eNeurologicalSci
Construct validity of the timed 25-foot walk and robustness of clinical benchmarks in multiple sclerosis: exploratory analyses of TEAMS study
By Salma Aly, Hui‐Ju Young, Tracy Flemming-Tracy and 4 others.
Loading your page…
Loading your page…
eNeurologicalSci
By Salma Aly, Hui‐Ju Young, Tracy Flemming-Tracy and 4 others.
Ward brings these articles into the same app as your cards and questions. One free account for Ward, Suture, Osler and Prognia.
The Timed 25-Foot Walk (T25-FW) is a widely used performance measure of ambulatory disability in multiple sclerosis (MS). Fewer studies have examined its construct validity relative to patient-reported outcomes or assessed robustness of previously proposed benchmarks in large cohorts.
To examine the construct validity of T25-FW using patient-reported health outcomes and to evaluate robustness of previously proposed clinical benchmarks.
Baseline data from 759 participants with MS enrolled in Tele-Exercise and Multiple Sclerosis (TEAMS) trial were analyzed. Associations between T25-FW performance and Short Form-36 physical functioning and emotional well-being subscales were evaluated using Spearman correlations. Previously proposed clinical benchmarks (<6 s, 6–7.99 s, ≥8 s) were evaluated in relation to patient-reported outcomes. Additional exploratory analyses included median-based anchors, segmented regression, and ROC methods.
T25-FW performance showed a strong association with SF-36 physical functioning (ρ = −0.71), which remained significant after adjustment for demographic factors (ρ = −0.39). In contrast, correlations with SF-36 emotional well-being were negligible. Stratification by established T25-FW clinical benchmarks demonstrated a clear gradient in physical functioning, with highest scores among participants completing the test in <6 s and lowest among those requiring ≥8 s or unable to perform test. Candidate cut points derived from multiple analytical approaches clustered around similar walking-time ranges and demonstrated consistent associations with physical functioning.
The T25-FW demonstrates strong construct validity with patient-reported physical functioning and clear divergent validity from emotional well-being. Findings support robustness of proposed T25-FW benchmark categories and reinforce the utility of T25-FW as measure of ambulatory disability in MS. Clinical trial registration: ClinicalTrials.gov Identifier: NCT03117881 .
Published in eNeurologicalSci. The abstract is shown as published and remains the work of its authors; read the full article at the source.
Prognia lists this article for reference and education. It is not medical advice. Always read the original and follow current guidelines and local protocols before acting on it.